Cardiovascular cryoablation tech developer Adagio Medical has raised approximately $7 million in a new round of equity and options financing, according to a recently posted SEC filing.
The company is looking to raise an additional $13 million, which would bring the total raised up to $20 million, according to the filing.
Adagio Medical is developing and producing ultra-low temperature cryoablation catheters intended to create endocardial, continuous, transmural lesions on the heart, according to the company’s website.
Money in the round came from seven unnamed sources, with the first date of sale noted as having occurred on February 26, according to the SEC filing.
Last December, Adagio Medical said that it launched its One Shot+ cryoablation catheter, and that the first patient has been treated with the device.